Inventor · disambiguated record
Jian Zhao
Also filed as: ZHAO JIAN · ZHAO JIAN-ZHOU
26 granted patents·15 pending applications·95 citations·filing 2003–2024
95Inventor score
Files withCRINETICS PHARMACEUTICALS INC25BEIJING MABWORKS BIOTECH CO LTD2RADIONETICS ONCOLOGY INC2TIANJIN TAIPU PHARMACEUTICAL SCI & TECH DEV CO LTD2UNIV BOSTON2
Top patents by PatentIndex Score
41 records- 0197US10981894B2Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereofCRINETICS PHARMACEUTICALS INC·Filed 2020·Granted Apr 20, 2021·6 cites·20 claims
- 0295US10766877B2Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereofCRINETICS PHARMACEUTICALS INC·Filed 2019·Granted Sep 8, 2020·7 cites·20 claims
- 0395US10604507B2Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereofCRINETICS PHARMACEUTICALS INC·Filed 2019·Granted Mar 31, 2020·7 cites·20 claims
- 0495US10562884B2Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereofCRINETICS PHARMACEUTICALS INC·Filed 2019·Granted Feb 18, 2020·7 cites·20 claims
- 0594US11566015B2Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereofCRINETICS PHARMACEUTICALS INC·Filed 2021·Granted Jan 31, 2023·2 cites·36 claims
- 0694US11479540B2Nonpeptide somatostatin type 5 receptor agonists and uses thereofCRINETICS PHARMACEUTICALS INC·Filed 2020·Granted Oct 25, 2022·5 cites·43 claims
- 0793US12134610B2Somatostatin subtype-2 receptor (SST2R) targeted therapeutics and uses thereofCRINETICS PHARMACEUTICALS INC·Filed 2024·Granted Nov 5, 2024·1 cites·29 claims
- 0893US10875839B2Somatostatin modulators and uses thereofCRINETICS PHARMACEUTICALS INC·Filed 2019·Granted Dec 29, 2020·5 cites·10 claims
- 0993US9896432B2Somatostatin modulators and uses thereofCRINETICS PHARMACEUTICALS INC·Filed 2017·Granted Feb 20, 2018·11 cites·20 claims
- 1092US10597377B2Somatostatin modulators and uses thereofCRINETICS PHARMACEUTICALS INC·Filed 2019·Granted Mar 24, 2020·8 cites·9 claims
- 1192US10351547B2Somatostatin modulators and uses thereofCRINETICS PHARMACEUTICALS INC·Filed 2017·Granted Jul 16, 2019·9 cites·24 claims
- 1292US9902703B2Somatostatin modulators and uses thereofCRINETICS PHARMACEUTICALS INC·Filed 2016·Granted Feb 27, 2018·8 cites·17 claims
- 1391US11414397B2Somatostatin modulators and uses thereofCRINETICS PHARMACEUTICALS INC·Filed 2020·Granted Aug 16, 2022·2 cites·23 claims
- 1491US9957267B2Somatostatin modulators and uses thereofCRINETICS PHARMACEUTICALS INC·Filed 2016·Granted May 1, 2018·8 cites·22 claims
- 1588US12479828B2Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereofCRINETICS PHARMACEUTICALS INC·Filed 2023·Granted Nov 25, 2025·0 cites·22 claims
- 1685US2024109866A1Melanocortin subtype-2 receptor (mc2r) antagonists and uses thereofCRINETICS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1782US10377833B2Bispecific anti-HER2 antibodyBEIJING MABWORKS BIOTECH CO LTD·Filed 2017·Granted Aug 13, 2019·3 cites·1 claims
- 1880US12442766B2Bond-selective intensity diffraction tomography and uses thereofUNIV BOSTON·Filed 2024·Granted Oct 14, 2025·0 cites·22 claims
- 1980US11608335B2Somatostatin modulators and uses thereofCRINETICS PHARMACEUTICALS INC·Filed 2019·Granted Mar 21, 2023·2 cites·21 claims
- 2080US2022380337A1Somatostatin modulators and uses thereofCRINETICS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2177US11913881B2Bond-selective intensity diffraction tomography and uses thereofUNIV BOSTON·Filed 2023·Granted Feb 27, 2024·0 cites·26 claims
- 2277US9745382B1Bispecific anti-HER2 antibodyBEIJING MABWORKS BIOTECH CO LTD·Filed 2017·Granted Aug 29, 2017·3 cites·20 claims
- 2374US2024376067A1Process of making somatostatin modulatorsCRINETICS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 2474US2024254106A1Somatostatin subtype-2 receptor (sst2r) targeted therapeutics and uses thereofCRINETICS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2567US2024285628A1Non-peptide targeted therapeutics and uses thereofCRINETICS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2667US2024408247A1Non-peptide targeted therapeutics and uses thereofCRINETICS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2766US2022144802A1Nonpeptide somatostatin type 5 receptor agonists and uses thereofCRINETICS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2864US2021087165A1Process of making somatostatin modulatorsCRINETICS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2961US9121031B2Methods and compositions for regulating production of proanthocyanidinsVERDIER JEROME A·Filed 2012·Granted Sep 1, 2015·1 cites·34 claims
- 3059US11193139B2Insecticidal proteins and methods for their usePIONEER HI BRED INT·Filed 2019·Granted Dec 7, 2021·0 cites·10 claims
- 3158US2024226343A1Neuropeptide y1 receptor (npy1r) targeted therapeutics and uses thereofRADIONETICS ONCOLOGY INC·Filed 2023·Application pending·0 cites
- 3257US2023405157A1Melanocortin type 2 receptor (mc2r) targeted therapeutics and uses thereofRADIONETICS ONCOLOGY INC·Filed 2023·Application pending·0 cites
- 3346US8536121B2Methods and reagents for the diagnosis, prevention and treatment of insulin resistance using beta-arrestin2 and its up-regulatorsPEI GANG·Filed 2009·Granted Sep 17, 2013·0 cites·5 claims
- 3444US2016193162A1Stable crystal i-form agomelatine tablet and preparation method thereofTIANJIN TAIPU PHARMACEUTICAL SCI & TECH DEV CO LTD·Filed 2014·Application pending·0 cites
- 3544US2016120825A1Stable crystal x-form agomelatine tablet and preparation method thereofTIANJIN TAIPU PHARMACEUTICAL SCI & TECH DEV CO LTD·Filed 2014·Application pending·0 cites
- 3644US2019327999A1Black Tea Extract and Preparation Method ThereforSHANGHAI KE BAO BIOTECH CO LTD·Filed 2017·Application pending·0 cites
- 3743US11028068B2Somatostatin modulators and uses thereofCRINETICS PHARMACEUTICALS INC·Filed 2018·Granted Jun 8, 2021·0 cites·19 claims
- 3843US2006057669A1Inactive transcription factor tif-ia and uses thereofGRUMMT INGRID·Filed 2003·Application pending·0 cites
- 3938US2011230421A1Fusion proteins of apoptin-protein transduction domain of carboxyl-terminus of ec-sodZHAO JIAN·Filed 2009·Application pending·0 cites
- 4037US9029420B2Agomelatine and pharmaceutical compositions thereofZHU JIANQIANG·Filed 2010·Granted May 12, 2015·0 cites·7 claims
- 4121US11566045B2Tumor targeting polypeptide and method of use thereofZHEJIANG REACHALL PHARMACEUTICAL CO LTD·Filed 2017·Granted Jan 31, 2023·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Jian Zhao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →